AMSTERDAM, The Netherlands and HUNTSVILLE, Alabama, July 5 /PRNewswire/
-- Kreatech Biotechnology BV and Open Biosystems today announced a
partnership whereby Open Biosystems will exclusively supply Kreatech's
ULS(TM) solutions to laboratories in the United States. The partnership will
expand US life science investigators access to innovative non-enzymatic
nucleic acid & protein labeling solutions.
Kreatech's Universal Linkage System (ULS(TM)) allows for the rapid
attachment of a variety of labels directly to DNA, RNA and proteins. These
products are centered around a proprietary platinum-based system that
produces highly stable labels under a wide variety of conditions. The ULS(TM)
products are available with a wide variety of industry standard dyes,
offering a versatile solution for the labeling of RNA in microarray and DNA
in CGH applications.
"This agreement expands our reach by leveraging Open Biosystems fast
growing sales and marketing team in the USA." said Alex Altink, Kreatech's
CEO. "We look forward to working with Open Biosystems and expanding our
international distribution network. In the next month's we expect to expand
our distribution network, both in Europe and Asia."
"This partnership will enable US life scientists to improve the
performance of their microarray and CGH experiments," said Troy Moore, Open
Biosystems' CTO. "We are excited to be offering these reagents from the
premier company in array labeling technologies."
About Kreatech Biotechnology
Kreatech Biotechnology B.V., a private company founded in 1990, focuses
on the creation, development, production and marketing of innovative
diagnostic and life science products. Kreatech's proprietary Universal
Linkage System (ULS(TM)) offers a reliable, robust and easy to use
non-enzymatic technology that can be applied to a broad range of biomolecules
and labeling agents. Kreatech is committed to achieve and maintain the
highest standards in production and Quality Control as well as in the
relationships with our customers and partners. The company's quality policies
are demonstrated by the implementation of ISO 9001 (2000) and ISO 13485 (GMP
2003) guidelines. More information on Kreatech can be accessed at
http://www.kreatech.com/
About Open Biosystems, Inc.
Open Biosystems develops, manufactures and markets genomic research tools
to scientist in academic, government and industrial laboratories. These
research tools provide investigators with standardized high-quality genes,
RNAi and antibodies for interrogating gene function in relation to oncology,
neuroscience and metabolic disorders. For more information, visit Open
Biosystems' website: http://www.openbiosystems.com/.

Return to Previous Page